Publication
Bactericidal efficacy of molybdenum oxide nanoparticles against antimicrobial-resistant pathogens
dc.contributor.author | Lopes, Elizeth | |
dc.contributor.author | Piçarra, S. | |
dc.contributor.author | Almeida, Pedro L. | |
dc.contributor.author | Lencastre, H. de | |
dc.contributor.author | Aires-de-Sousa, Marta | |
dc.date.accessioned | 2019-01-29T10:40:35Z | |
dc.date.available | 2019-01-29T10:40:35Z | |
dc.date.issued | 2018-08 | |
dc.description.abstract | Multidrug-resistant bacteria pose a major threat to effective antibiotics and alternatives to fight multidrug-resistant pathogens are needed. We synthetized molybdenum oxide (MoO3) nanoparticles (NP) and determined their antibacterial activity against 39 isolates: (i) eight Staphylococcus aureus, including representatives of methicillin-resistant S. aureus epidemic clones; (ii) six enterococci, including vancomycin-resistant isolates; and (iii) 25 Gram-negative isolates (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, Enterobacter cloacae), including extended spectrum beta-lactamases and carbapenemases producers. All isolates showed a MoO3 NP MIC of 700–800 mg l−1. MoO3 NP produced a clear inhibition zone for S. aureus and all Gram-negative isolates at concentrations ≥25 mg ml−1 and ≥50 mg ml−1 for enterococci. When the NP solutions were adjusted to pH ~7, the biocidal activity was completely abolished. MoO3 NP create an acidic pH and show a universal antimicrobial activity against susceptible and resistant isolates belonging to the most relevant bacterial species responsible for hospital-acquired infections. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | LOPES, E.; [et al] – Bactericidal efficacy of molybdenum oxide nanoparticles against antimicrobial-resistant pathogens. Journal of Medical Microbiology. ISSN 0022-2615. Vol. 67, N.º 8 (2018), pp. 1042-1046 | pt_PT |
dc.identifier.doi | 10.1099/jmm.0.000789 | pt_PT |
dc.identifier.issn | 0022-2615 | |
dc.identifier.uri | http://hdl.handle.net/10400.21/9371 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Microbiology Society | pt_PT |
dc.relation | PTDC/FIS/NAN/0117/2014 | pt_PT |
dc.relation | LISBOA-01-0145-FEDER-007660 - Microbiologia Molecular, Estrutural e Celular | pt_PT |
dc.relation | 03/BI/2017 - FCT | pt_PT |
dc.subject | Molybdenum oxide | pt_PT |
dc.subject | Nanoparticles | pt_PT |
dc.subject | Multidrug-resistant bacteria | pt_PT |
dc.subject | Bactericidal efficacy | pt_PT |
dc.subject | Nanopartículas | pt_PT |
dc.subject | Bactérias multirresistentes | pt_PT |
dc.title | Bactericidal efficacy of molybdenum oxide nanoparticles against antimicrobial-resistant pathogens | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FDTP-EPI%2F0842%2F2014/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/5876/UID%2FCTM%2F50025%2F2013/PT | |
oaire.citation.endPage | 1046 | pt_PT |
oaire.citation.issue | 8 | pt_PT |
oaire.citation.startPage | 1042 | pt_PT |
oaire.citation.title | Journal of Medical Microbiology | pt_PT |
oaire.citation.volume | 67 | pt_PT |
oaire.fundingStream | 3599-PPCDT | |
oaire.fundingStream | 5876 | |
person.familyName | Lopes | |
person.familyName | Marques de Almeida | |
person.familyName | Aires-de-Sousa | |
person.givenName | Elizeth | |
person.givenName | Pedro | |
person.givenName | Marta | |
person.identifier.ciencia-id | E51A-817A-39AE | |
person.identifier.ciencia-id | 0218-71B2-2DE0 | |
person.identifier.ciencia-id | CC11-681F-CED1 | |
person.identifier.orcid | 0000-0002-9837-5155 | |
person.identifier.orcid | 0000-0001-7356-8455 | |
person.identifier.orcid | 0000-0001-5036-2446 | |
person.identifier.rid | B-4356-2009 | |
person.identifier.scopus-author-id | 57190384213 | |
person.identifier.scopus-author-id | 6603316273 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.rights | closedAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 12cae01b-7861-4c2d-8d37-677271705baa | |
relation.isAuthorOfPublication | 429b6d71-328e-42b3-8151-15493de249b8 | |
relation.isAuthorOfPublication | f3537080-62cc-4b0d-9e47-1a7ea3df7b63 | |
relation.isAuthorOfPublication.latestForDiscovery | f3537080-62cc-4b0d-9e47-1a7ea3df7b63 | |
relation.isProjectOfPublication | e19c452a-0b77-4fdf-a79b-e1e0e606eac2 | |
relation.isProjectOfPublication | e7fba2ab-23e9-40ca-a6de-695e974393e6 | |
relation.isProjectOfPublication.latestForDiscovery | e7fba2ab-23e9-40ca-a6de-695e974393e6 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- 2018 J Med Microbiol 67 1042–1046.pdf
- Size:
- 1.5 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: